Maria Sharapova dope controversy: Timeline of the entire case

Jun 09, 2016, 08:30 IST | Agencies

Here is a look at how the entire doping issue unfolded with Russian tennis star Maria Sharapova

Jan 26, 2016: Loses in Australian Open quarter-final to rival Serena Williams

Maria Sharapova. Pic/AFPMaria Sharapova. Pic/AFP

March 7: Calls press conference in Los Angeles, where she reveals she tested positive for endurance-boosting drug meldonium (a substance banned on WADA’s list since Jan this year) after her loss in Melbourne.

March 8: Nike, Tag Heuer and Porsche snap lucrative relationship with Sharapova.

March 8: Rival Williams praises her “courage” in fronting up to developments.

March 9: WADA president Dick Pound describes Sharapova’s actions as “reckless beyond description”.

March 10: Racquet manufacturer Head stands by the Russian.

March 12: Contrary to media reports, Sharapova insists she had not received separate warnings about changes to anti-doping rules.

March 15: United Nations suspends Sharapova as goodwill ambassador.

March 24: WADA says 123 cases involving meldonium recorded since the drug was banned on January 1.

April 13: WADA says athletes may escape a ban for taking meldonium as its not known how long it takes the substance to leave the body.

April 14: Russian President Vladimir Putin says that athletes’ use of meldonium does not constitute doping.

May 26: Sharapova is named on Russian Olympic tennis team.

June 7: Sharapova earnings of $21.9 million over the past 12 months is down almost $8 million from the previous year, according to Forbes magazine.

June 8: Banned for two years by ITF, Sharapova announces she will appeal to Court of Arbitration for Sport.

Go to top